MedTrace Logo

"Association of Proteinuria and Progression of Kidney Dysfunction in Sickle Cell Disease"Disease

NCT05407740 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 355

Last updated 2024-05-16

No results posted yet for this study

Summary

To describe change in ACR and eGFR during study follow-up, and assesss the association of baseline and change in ACR and eGFR, with progression of kidney failure and/or all-cause mortality.

Conditions

  • Change in Albumin to Creatinine Ratio and Glomerular Filtration Rate
  • Progression of Kidney Failure and or All-cause Mortality

Interventions

OTHER

no intervention study

no intervention study

Sponsors & Collaborators

  • Novartis

    collaborator INDUSTRY

  • Soutien aux Actions contre les Maladies du Globule Rouge

    lead OTHER

Principal Investigators

  • PABLO BARTOLUCCI, PROFESSOR · Soutien aux Actions contre les Maladies du Globule Rouge

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-03-01
Primary Completion
2021-03-01
Completion
2021-12-01

Countries

  • France

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05407740 on ClinicalTrials.gov